REVANCE THERAPEUTICS INC - NOTE 1.750% 2/1

Q3 2022 13F Holders as of 9/30/2022

Type / Class
Debt / NOTE 1.750% 2/1
Number of holders
27
Total Principal
308M
Shares change
-6.63M
Total reported value, excl. options
$337M
Value change
-$6.83M
Put/Call ratio
0
Number of buys
12
Number of sells
-9
Price
$1.09
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.